Literature DB >> 2162173

Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid.

J L Masferrer1, A P Rios, M L Schwartzman.   

Abstract

12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid [12(R)-HETE] is one of the major arachidonate metabolites of the corneal epithelial cytochrome P450 system. We studied its inhibitory effect on different preparations of (Na(+)-K+)ATPase. 12(R)-HETE had no effect on ATPase activity in the absence of Na+ and K+. However, it inhibited ouabain-sensitive (Na(+)-K+)ATPase obtained from bovine corneal epithelium, rat kidney and rat heart ventricle in a concentration-dependent manner with an IC50 of 10(-6) M. Its enantiomer, 12(S)-HETE, was inactive at 10(-7) M and 10(-6) M, but it inhibited (Na(+)-K+)ATPase at higher doses, an effect also seen with arachidonic acid. 12(R)-HETE as an endogenous metabolite of arachidonic acid may modulate physiological and pathophysiological processes by affecting (Na(+)-K+)ATPase activities in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162173     DOI: 10.1016/0006-2952(90)90617-t

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Modification of membrane fatty acid composition, eicosanoid production, and phospholipase A activity in Atlantic salmon (Salmo salar) gill and kidney by dietary lipid.

Authors:  J G Bell; B M Farndale; J R Dick; J R Sargent
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

Review 2.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

Review 3.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

Review 4.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

6.  The effect of dietary linoleic acid on the fatty acid composition of individual phospholipid and lipoxygenase products from gills and leucocytes of Atlantic salmon (Salmo salar).

Authors:  J Gordon Bell; R S Raynard; J R Sargent
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

7.  Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension.

Authors:  Bruce I Gaynes; Anne Onyekwuluje
Journal:  Clin Ophthalmol       Date:  2008-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.